That left room for Johnson & Johnson’s Tremfya to jump up to the second spot, while Novo Nordisk’s megapopular obesity med Wegovy—a recent addition to iSpot.TV’s pharma ad spending ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback